Table 2. Biomarkers for the application of type 2 antagonists.

Target	Drug Name	Biomarker	Reference
IL-13	Lebrikizumab	Periostin	33
IL-13	Tralokinumab	Periostin/DPP4	55
IL-4R	Dupilumab	Eosinophil	56
IL-5	Mepolizumab	Eosinophil	27, 28
IL-5	Reslizumab	Eosinophil	57
IL-5R	Benralizumab	Eosinophil	58
CRTH2	OC459/ODC9101	Eosinophil	59